Viewing Study NCT06429761


Ignite Creation Date: 2025-12-24 @ 12:03 PM
Ignite Modification Date: 2026-02-23 @ 2:21 AM
Study NCT ID: NCT06429761
Status: RECRUITING
Last Update Posted: 2025-11-24
First Post: 2024-05-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 4 Study to Assess the Safety of Trastuzumab Deruxtecan, in Indian Patients
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module